1-deoxynojirimycin has been researched along with Alloxan Diabetes in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (20.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 4 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, N; Chen, FJ; Haruno, M; Kato, A; Kimura, I; Nojima, H; Sugihara, Y | 1 |
| He, X; Ma, K; Mei, Y; Sun, Z | 1 |
| Dong, Y; Han, A; He, L; Jia, Q; Ren, X; Xing, Y; Xiu, Z; Yang, L | 1 |
| Chen, JG; Lin, P; Peng, DY; Tang, DB; Tu, YG; Xiao, PJ; Yin, ZP; Yuan, E; Zeng, JC; Zhang, QF | 1 |
| Chai, T; Du, HY; Jiang, Y; Li, L; Xu, H; Zhang, Y | 1 |
| Hu, GY; Ji, DF; Li, YG; Lin, TB; Lv, ZQ; Wang, X; Zhong, S | 1 |
| Ji, DF; Li, YG; Lin, TB; Lv, ZQ; Zhong, S | 2 |
| Abe, H; Fujitani, Y; Hara, A; Ishibashi, K; Kanazawa, A; Kawamori, R; Komiya, K; Ogihara, T; Tamaki, M; Uchida, T; Watada, H | 1 |
| Hirata, A; Igarashi, M; Iwai, H; Tominaga, M | 1 |
| Fukaya, N; Goda, T; Mochizuki, K; Shimada, M; Tanaka, Y | 1 |
| Fukaya, N; Goda, T; Mochizuki, K; Shimada, M | 1 |
| Chen, S; Hu, GY; Ji, DF; Li, YG; Lin, TB; Lv, ZQ; Zhong, S | 1 |
| Fuchigami, M; Furuta, S; Hamada, Y; Nagasaki, H; Nakamura, J; Oiso, Y; Seino, Y | 1 |
| Bischoff, H | 1 |
| Campillo, JE; Martinez, IM; Nieto, M; Ropero, MF; Tormo, MA | 1 |
| Madar, Z | 2 |
| Bezerra, J; Bustamante, S; Flores, C; Goda, T; Koldovský, O; Lee, SM | 1 |
| Madar, Z; Olefsky, J | 1 |
1 review(s) available for 1-deoxynojirimycin and Alloxan Diabetes
| Article | Year |
|---|---|
Pharmacology of alpha-glucosidase inhibition.
Topics: 1-Deoxynojirimycin; Acarbose; Animals; Blood Glucose; Carbohydrate Sequence; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diabetic Neuropathies; Dietary Carbohydrates; Digestion; Glucosamine; Glycation End Products, Advanced; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Molecular Sequence Data; Trisaccharides | 1994 |
19 other study(ies) available for 1-deoxynojirimycin and Alloxan Diabetes
| Article | Year |
|---|---|
Antihyperglycemic effects of N-containing sugars from Xanthocercis zambesiaca, Morus bombycis, Aglaonema treubii, and Castanospermum australe in streptozotocin-diabetic mice.
Topics: Animals; Blood Glucose; Carbohydrates; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Fabaceae; Hypoglycemic Agents; In Vitro Techniques; Insulin; Male; Mice; Mice, Inbred Strains; Pancreas; Plant Extracts; Plants, Medicinal; Rats; Rats, Wistar; Time Factors | 1998 |
[1-deoxynojirimycin alleviates liver fibrosis induced by type 2 diabetes in mice].
Topics: 1-Deoxynojirimycin; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Liver Cirrhosis; Mice; Mice, Inbred C57BL | 2021 |
Effect of 1-Deoxynojirimycin on insulin resistance in prediabetic mice based on next-generation sequencing and intestinal microbiota study.
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Progression; Gastrointestinal Microbiome; High-Throughput Nucleotide Sequencing; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Morus; Prediabetic State; Streptozocin | 2022 |
Chalcone-1-Deoxynojirimycin Heterozygote Reduced the Blood Glucose Concentration and Alleviated the Adverse Symptoms and Intestinal Flora Disorder of Diabetes Mellitus Rats.
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Chalcone; Chalcones; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gastrointestinal Microbiome; Heterozygote; Hypoglycemic Agents; Rats | 2022 |
Mulberry leaf multi-components exert hypoglycemic effects through regulation of the PI-3K/Akt insulin signaling pathway in type 2 diabetic rats.
Topics: 1-Deoxynojirimycin; Adipokines; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Morus; Phosphatidylinositol 3-Kinases; Plant Leaves; Polysaccharides; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2024 |
1-deoxynojirimycin inhibits glucose absorption and accelerates glucose metabolism in streptozotocin-induced diabetic mice.
Topics: 1-Deoxynojirimycin; Animals; Biological Transport; Blood Glucose; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Gluconeogenesis; Glucose; Glucose Transport Proteins, Facilitative; Glucose Transporter Type 2; Glycolysis; Intestinal Absorption; Intestinal Mucosa; Intestines; Male; Mice; Mice, Inbred ICR; RNA, Messenger; Sodium-Glucose Transporter 1; Sodium-Potassium-Exchanging ATPase; Streptozocin | 2013 |
Cooperative anti-diabetic effects of deoxynojirimycin-polysaccharide by inhibiting glucose absorption and modulating glucose metabolism in streptozotocin-induced diabetic mice.
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Blotting, Western; Diabetes Mellitus, Experimental; Glucose; Insulin; Liver; Male; Mice; Mice, Inbred ICR; Polysaccharides; Streptozocin | 2013 |
Beneficial effects of vildagliptin combined with miglitol on glucose tolerance and islet morphology in diet-controlled db/db mice.
Topics: 1-Deoxynojirimycin; Adamantane; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glucose Tolerance Test; Hypoglycemic Agents; Islets of Langerhans; Male; Mice; Mice, Inbred Strains; Nitriles; Pyrrolidines; Vildagliptin | 2013 |
Hypoglycemic effect of deoxynojirimycin-polysaccharide on high fat diet and streptozotocin-induced diabetic mice via regulation of hepatic glucose metabolism.
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Blotting, Western; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fructose-Bisphosphatase; Glucokinase; Glucosamine; Glucose-6-Phosphatase; Hypoglycemic Agents; Insulin Resistance; Liver; Male; Mice; Mice, Inbred ICR; Phosphoenolpyruvate Carboxykinase (ATP); Phosphofructokinase-1, Liver Type; Pyruvate Carboxylase; Pyruvate Decarboxylase; Random Allocation | 2015 |
Effect of miglitol, an alpha-glucosidase inhibitor, on atherogenic outcomes in balloon-injured diabetic rats.
Topics: 1-Deoxynojirimycin; Animals; Atherosclerosis; Blood Glucose; Catheterization; Diabetes Mellitus, Experimental; Dietary Fats; Hypoglycemic Agents; Male; Rats; Rats, Wistar | 2009 |
The alpha-glucosidase inhibitor miglitol suppresses postprandial hyperglycaemia and interleukin-1beta and tumour necrosis factor-alpha gene expression in rat peripheral leucocytes induced by intermittent sucrose loading.
Topics: 1-Deoxynojirimycin; Animals; Diabetes Mellitus, Experimental; Dietary Sucrose; Gene Expression; Glycoside Hydrolase Inhibitors; Hyperglycemia; Interleukin-1beta; Leukocytes, Mononuclear; Male; Models, Animal; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Sweetening Agents; Tumor Necrosis Factor-alpha | 2009 |
The alpha-glucosidase inhibitor miglitol decreases glucose fluctuations and gene expression of inflammatory cytokines induced by hyperglycemia in peripheral leukocytes.
Topics: 1-Deoxynojirimycin; Animals; Area Under Curve; Blood Glucose; Cytokines; Diabetes Mellitus, Experimental; Dietary Sucrose; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Leukocytes; Male; Microarray Analysis; Random Allocation; Rats; Rats, Wistar; RNA, Messenger; Streptozocin; Up-Regulation | 2009 |
Hybrid of 1-deoxynojirimycin and polysaccharide from mulberry leaves treat diabetes mellitus by activating PDX-1/insulin-1 signaling pathway and regulating the expression of glucokinase, phosphoenolpyruvate carboxykinase and glucose-6-phosphatase in allox
Topics: 1-Deoxynojirimycin; Alloxan; Animals; Base Sequence; Diabetes Mellitus, Experimental; DNA Primers; Gene Expression Regulation, Enzymologic; Glucokinase; Glucose Tolerance Test; Glucose-6-Phosphatase; Homeodomain Proteins; Insulin; Male; Mice; Mice, Inbred ICR; Morus; Phosphoenolpyruvate Carboxykinase (ATP); Plant Leaves; Polysaccharides; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Trans-Activators | 2011 |
The alpha-glucosidase inhibitor miglitol affects bile acid metabolism and ameliorates obesity and insulin resistance in diabetic mice.
Topics: 1-Deoxynojirimycin; Animals; Bile Acids and Salts; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Hep G2 Cells; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Mice; Obesity; Rats; Rats, Wistar | 2013 |
In vitro study of the effect of miglitol on carbohydrate digestion and intestinal metabolism in normal and non-insulin-dependent diabetic rats.
Topics: 1-Deoxynojirimycin; Animals; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucosamine; Glycoside Hydrolase Inhibitors; Imino Pyranoses; In Vitro Techniques; Intestinal Absorption; Intestine, Small; Male; Perfusion; Rats; Rats, Wistar | 1996 |
Metabolic consequences of the alpha-glucosidase inhibitor BAY-M-1099 given to nondiabetic and diabetic rats fed a high-carbohydrate diet.
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Diet; Dietary Carbohydrates; Glucosamine; Glycoside Hydrolase Inhibitors; Glycosuria; Imino Pyranoses; Male; Rats; Rats, Inbred Strains; Sucrose; Triglycerides | 1989 |
The effect of acarbose and miglitol (BAY-M-1099) on postprandial glucose levels following ingestion of various sources of starch by nondiabetic and streptozotocin-induced diabetic rats.
Topics: 1-Deoxynojirimycin; Acarbose; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Eating; Glucosamine; Glucose; Glucosidases; Imino Pyranoses; Insulin; Male; Rats; Starch; Trisaccharides | 1989 |
Chronic effects of an alpha-glucosidase inhibitor (Bay o 1248) on intestinal disaccharidase activity in normal and diabetic mice.
Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Animals; beta-Galactosidase; Body Weight; Diabetes Mellitus, Experimental; Disaccharidases; Eating; Glucosamine; Glycoside Hydrolase Inhibitors; Intestine, Small; Mice; Mice, Inbred C57BL; Sucrase | 1987 |
Effect of the alpha-glucosidase inhibitor Bay-O-1248 on the metabolic response of nondiabetic and diabetic rats to a high-carbohydrate diet.
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Experimental; Dietary Carbohydrates; Glucosamine; Glycosuria; Male; Rats; Rats, Inbred Strains; Triglycerides | 1986 |